Article Type
Changed
Mon, 04/15/2019 - 09:09
Display Headline
When and how to use serum tumor markers in clinical practice
Article PDF
Author and Disclosure Information

Maurie Markman, MD
Chairman of the Department of Hematology/Medical Oncology at the Cleveland Clinic, and an associate editor of the Cleveland Clinic Journal of Medicine.

Address: Maurie Markman, MD, Department of Hematology/Medical Oncology,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Issue
Cleveland Clinic Journal of Medicine - 64(1)
Publications
Page Number
27-29
Sections
Author and Disclosure Information

Maurie Markman, MD
Chairman of the Department of Hematology/Medical Oncology at the Cleveland Clinic, and an associate editor of the Cleveland Clinic Journal of Medicine.

Address: Maurie Markman, MD, Department of Hematology/Medical Oncology,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Author and Disclosure Information

Maurie Markman, MD
Chairman of the Department of Hematology/Medical Oncology at the Cleveland Clinic, and an associate editor of the Cleveland Clinic Journal of Medicine.

Address: Maurie Markman, MD, Department of Hematology/Medical Oncology,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 64(1)
Issue
Cleveland Clinic Journal of Medicine - 64(1)
Page Number
27-29
Page Number
27-29
Publications
Publications
Article Type
Display Headline
When and how to use serum tumor markers in clinical practice
Display Headline
When and how to use serum tumor markers in clinical practice
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media